(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.47%) $78.48
(1.31%) $2.17
(-0.19%) $2 304.20
(0.15%) $26.73
(-0.51%) $960.35
(0.05%) $0.929
(-0.11%) $10.86
(0.02%) $0.797
(0.00%) $91.45
2 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 18.00%
4.50% $ 1.160
@ $1.110
Emitido: 14 feb 2024 @ 09:32
Retorno: 4.50%
Señal anterior: feb 13 - 09:30
Señal anterior:
Retorno: 2.30 %
Live Chart Being Loaded With Signals
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease...
Stats | |
---|---|
Volumen de hoy | 4.46M |
Volumen promedio | 4.42M |
Capitalización de mercado | 175.17M |
EPS | $0 ( 2024-03-05 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.300 |
ATR14 | $0.00700 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-04 | Graves Kurt | Buy | 60 000 | Stock Option (right to buy) |
2024-04-04 | Kender Richard N | Buy | 60 000 | Stock Option (right to buy) |
2024-04-04 | Biondi Paul | Buy | 60 000 | Stock Option (Right to Buy) |
2024-04-04 | Fraser Claire | Buy | 60 000 | Stock Option (right to buy |
2024-04-04 | Dere Willard H | Buy | 60 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
92.36 |
Last 99 transactions |
Buy: 7 007 921 | Sell: 289 369 |
Volumen Correlación
Seres Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
RRGB | 0.897 |
FRSH | 0.892 |
WSBF | 0.888 |
EVCM | 0.884 |
SVC | 0.882 |
RDUS | 0.881 |
ALHC | 0.879 |
DMTK | 0.877 |
TWKS | 0.876 |
LPSN | 0.871 |
10 Correlaciones Más Negativas | |
---|---|
KINS | -0.881 |
EDAP | -0.88 |
FBIOP | -0.88 |
XLRN | -0.876 |
RETA | -0.873 |
JUPW | -0.87 |
RDNT | -0.865 |
CRDF | -0.864 |
LAB | -0.864 |
ACGL | -0.864 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Seres Therapeutics Inc Correlación - Moneda/Commodity
Seres Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $126.33M |
Beneficio Bruto: | $111.21M (88.04 %) |
EPS: | $-0.890 |
FY | 2023 |
Ingresos: | $126.33M |
Beneficio Bruto: | $111.21M (88.04 %) |
EPS: | $-0.890 |
FY | 2022 |
Ingresos: | $7.13M |
Beneficio Bruto: | $6.12M (85.91 %) |
EPS: | $-2.35 |
FY | 2021 |
Ingresos: | $144.93M |
Beneficio Bruto: | $144.93M (100.00 %) |
EPS: | $-0.720 |
Financial Reports:
No articles found.
Seres Therapeutics Inc
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteria microbiome drug, which is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation and solid organ transplants. In addition, the company engages in the development of SER-287 and SER-301 that are in Phase Ib to treat ulcerative colitis; SER-401 for patients with metastatic melanoma; and SER-262 to treat Clostridioides difficile infection. It has license and collaboration agreements with Nestec Ltd. and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico